Immediate Impact
2 by Nobel laureates 5 from Science/Nature 55 standout
Citing Papers
Reteplase versus Alteplase for Acute Ischemic Stroke
2024 Standout
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2023 Standout
Works of Andreas Jessel being referenced
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
2021 Standout
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)
1994
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andreas Jessel | 596 | 440 | 271 | 16 | 1.2k | |
| Anjan Chakrabarti | 433 | 240 | 159 | 22 | 934 | |
| Larry L. Shears | 266 | 327 | 181 | 22 | 1.3k | |
| Richard S. Pavelec | 506 | 243 | 305 | 13 | 1.0k | |
| Jacob Gurevitch | 626 | 621 | 224 | 26 | 1.0k | |
| J.F. Martin | 551 | 251 | 177 | 32 | 1.3k | |
| Vlasios Pyrgakis | 733 | 239 | 166 | 35 | 1.3k | |
| Neil K. Worrall | 201 | 379 | 188 | 23 | 1.2k | |
| Marc R. Litt | 574 | 720 | 194 | 18 | 1.3k | |
| Elizabeth N. Morgan | 229 | 220 | 191 | 17 | 1.0k | |
| Rosmarie Leiderer | 203 | 514 | 183 | 18 | 1.3k |
All Works
Loading papers...